Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
5
Bearish filings
4
Named actors
5
Disclosed $ (bull / bear)
$60.3M / $3.3M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-06-04 | Chief Financial Officer BORGESON JOHN A. | sold | $881K | SEC ↗ |
| 2026-06-04 | Chief Financial Officer BORGESON JOHN A. | sold | $142K | SEC ↗ |
| 2026-06-04 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JOHN BORGESON | filed notice to sell | $1.0M | SEC ↗ |
| 2026-04-02 | 5%+ holder (13G) Point72 Asset Management, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-04-02 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JOHN BORGESON | filed notice to sell | $1.3M | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-03-25 | Chairman and CEO PERLROTH VICTOR | exercised options & held the shares | $312K | — |
| 2025-12-18 | Director Baker Brothers Life Sciences LP | bought | $55.0M | SEC ↗ |
| 2025-12-18 | Director Baker Brothers Life Sciences LP | bought | $5.0M | SEC ↗ |
| 2025-08-19 | 5%+ holder (13G) Point72 Asset Management, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |